Filing Flows

Filing Flows › Merck (MRK) › Q3 2025

Merck (MRK) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 5, 2025

Merck (MRK) reported revenue of $17.3B for the third quarter 2025 (Q3 2025), +4% from a year earlier and +9% from the quarter before. Operating margin was 39.0%, net earnings $5.8B (33.5% of revenue).

Revenue$17.3B
Year over year+4%
Quarter over quarter+9%
Operating margin39.0%
Net earnings$5.8B

Merck, Q3 2025: revenue $17.3B (+4% year over year), operating margin 39.0%, net earnings $5.8B, operating cash flow $7.8B. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$17.3B+9%+4%
Operating profit$6.7B+35%+65%
Net earnings$5.8B+31%+83%
Operating cash flow$7.8B+138%-16%
Free cash flow$6.8B+170%-20%

What changed

Revenue was $17.3B in Q3 2025, up 4% year over year and up 9% from the previous quarter.

Operating profit was $6.7B, a 39.0% margin (up 14.5 points year over year). Of the extra revenue versus a year earlier, 429% reached operating profit, above the 25% margin then. Total costs fell 16% while revenue rose 4%. Net earnings were $5.8B, up 83% year over year. The effective tax rate was 14.2%.

Operating cash flow was $7.8B (down 16% year over year), 135% of net earnings. Non-cash charges added back $0.53B of depreciation and $0.20B of share-based compensation. Working capital and other items added $1.3B. Capital expenditures of $1.0B left free cash flow of $6.8B.

Questions

What was Merck's revenue in the third quarter 2025?

Merck (MRK) reported revenue of $17.3B for the third quarter 2025 (Q3 2025), +4% from a year earlier and +9% from the quarter before.

Was Merck profitable in the third quarter 2025?

Operating profit was $6.7B (39.0% of revenue) and net earnings $5.8B.

Open the interactive Sankey →

Source: Merck 10-Q on SEC EDGAR.